Displaying items by tag: center for aids research

Researchers hope to learn whether the immune system will respond to the experimental vaccines by making antibodies and T cells that could fight HIV if a person is ever exposed to the virus in the future.
Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
Tagged under

Get answers to some of today’s most common questions about COVID, the Delta variant, vaccines, masking and more in these YouTube videos — perfect for sharing on social media.

MicroCT of infected human lung tissue, along with histology and immunohistochemistry, was used to construct images of TB granulomas, airways and vasculature.

A comprehensive health-screening program in rural northern KwaZulu-Natal has found a high burden of undiagnosed or poorly controlled non-communicable diseases.

Despite extensive knowledge about HIV, the number of cases of incident HIV infection has decreased only 7 percent over the past decade.
New recommendations for treatment and prevention of HIV infection in adults will help guide physicians and patients in HIV therapies and treatment regimens.
A renowned UAB HIV/AIDS researcher and physician has been named editor of a prominent peer-reviewed journal.
In a new trial led by the NIH, researchers will evaluate whether a long-acting medication will be beneficial for patients who are not normally consistent with medication.
UAB investigators hope the Emergency Department medication assisted treatment program will help curtail opioid use disorder.
NIH research funding to the UAB School of Medicine has increased by more than $100 million in the past five years, a barometer of the school’s success.
Page 1 of 3